Jan Debruyne

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

PET visualization of microglia in multiple sclerosis patients using [¹¹C]PK11195

Jan Debruyne, Jan Versijpt, K. J. Van Laere et al. · European Journal of Neurology · 2003 · 216 citations

Medicine, Neurology, Nuclear Medicine +17

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)

W. Oliver Tobin, Yong Guo, Karl N. Krecke et al. · Brain · 2017 · 201 citations · Full text

Medicine, Neurology, Pathology +15

Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study

Jan Versijpt, Jan Debruyne, K. J. Van Laere et al. · Multiple Sclerosis Journal · 2005 · 123 citations

Medicine, Neurology, Neuroscience +17

Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis

Dirk De Ridder, Frank Van der Aa, Jan Debruyne et al. · Clinical Neurology and Neurosurgery · 2013 · 56 citations

Medicine, Neurology, Neuroscience +16